RankAlpha logo
Back to Rankings

ENGN

enGene TherapeuticsB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
ENGN vs peer average
79/100
ENGN vs. peer average (B vs. D)
Grade spread
B 2 · C 2 · D 3 · F 4
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

CGON is the first available peer comparator.

Closest clinical comparator because cretostimogene is being developed in BCG-unresponsive NMIBC with CIS; useful for judging the efficacy and durability bar.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerCGONCG Oncology
ENGN
enGene Therapeutics
CGON
CG Oncology
Grade
B
D
Momentum
46
55
Value
58
41
Sentiment
68
49
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive

Grade position vs CGON

ENGN / CGON
Grade Position
Above peers
ENGN vs. peer average (B vs. D)
79/100
Momentum
46
CGON
Value
58
ENGN
Sentiment
68
ENGN

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ENGN
1
CGON
CGON
D
40/100
+2
2
IBRX
IBRX
C
60/100
+1
3
MRK
MRK
C
60/100
+1
4
BGM
BGM Group Ltd Class A Common
F
20/100
+3
5
CPIX
Cumberland Pharmaceuticals Inc Common
B
80/100
Even
CGON is the first peer returned for this comparison set.